Annual Accounts Receivable
$18.51 M
+$3.65 M+24.52%
December 31, 2024
Summary
- As of March 9, 2025, RYTM annual accounts receivable is $18.51 million, with the most recent change of +$3.65 million (+24.52%) on December 31, 2024.
- During the last 3 years, RYTM annual accounts receivable has risen by +$17.49 million (+1706.05%).
- RYTM annual accounts receivable is now at all-time high.
Performance
RYTM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$18.51 M
-$794.00 K-4.11%
December 31, 2024
Summary
- As of March 9, 2025, RYTM quarterly accounts receivable is $18.51 million, with the most recent change of -$794.00 thousand (-4.11%) on December 31, 2024.
- Over the past year, RYTM quarterly accounts receivable has dropped by -$794.00 thousand (-4.11%).
- RYTM quarterly accounts receivable is now -4.11% below its all-time high of $19.31 million, reached on September 30, 2024.
Performance
RYTM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RYTM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.5% | -4.1% |
| 3 y3 years | +1706.0% | +1706.0% |
| 5 y5 years | - | +1706.0% |
RYTM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1706.0% | -4.1% | +2047.6% |
| 5 y | 5-year | at high | -100.0% | -4.1% | -100.0% |
| alltime | all time | at high | -100.0% | -4.1% | -100.0% |
Rhythm Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $18.51 M(+24.5%) | $18.51 M(-4.1%) |
| Sep 2024 | - | $19.31 M(+9.7%) |
| Jun 2024 | - | $17.60 M(+19.8%) |
| Mar 2024 | - | $14.70 M(-1.2%) |
| Dec 2023 | $14.87 M | $14.87 M(+2.2%) |
| Sep 2023 | - | $14.54 M(+5.1%) |
| Jun 2023 | - | $13.83 M(+70.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $8.12 M(+30.4%) |
| Dec 2022 | $6.22 M(+507.2%) | $6.22 M(+87.0%) |
| Sep 2022 | - | $3.33 M(+95.0%) |
| Jun 2022 | - | $1.71 M(+98.0%) |
| Mar 2022 | - | $862.00 K(-15.9%) |
| Dec 2021 | $1.02 M(>+9900.0%) | $1.02 M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Rhythm Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual accounts receivable year-on-year change?
- What is Rhythm Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Rhythm Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of RYTM is $18.51 M
What is the all time high annual accounts receivable for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual accounts receivable is $18.51 M
What is Rhythm Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, RYTM annual accounts receivable has changed by +$3.65 M (+24.52%)
What is Rhythm Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of RYTM is $18.51 M
What is the all time high quarterly accounts receivable for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly accounts receivable is $19.31 M
What is Rhythm Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, RYTM quarterly accounts receivable has changed by -$794.00 K (-4.11%)